PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype.
Foley
R
R
Soamboonsrup
P
P
Kouroukis
T
T
Leber
B
B
Carter
R F
RF
Sunisloe
L
L
Chorneyko
K
K
Neame
P B
PB
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics*; D006801:Humans; D016130:Immunophenotyping; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis*; D015514:Oncogene Proteins, Fusion / Q000032:analysis*; D013234:Stem Cells; D014178:Translocation, Genetic / Q000235:genetics*
D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein